293301-09-4

Basic information

• Product Name: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine
• Synonyms: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine
• CAS NO: 293301-09-4
• Molecular Weight: 296.329
• Mol File: 293301-09-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine(293301-09-4)
• EPA Substance Registry System: 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamine(293301-09-4)

Safety Data

• Hazardous Substances Data: 293301-09-4(Hazardous Substances Data)

Upstream product

• 311819-99-5 3-(3,5-dimethoxyphenyl)-7-(tritylamino)-1,6-naphthyridin-2-ylformamide 
• 311820-00-5 3-(3,5-dimethoxyphenyl)-N⁷-trityl-1,6-naphthyridine-2,7-diamine 
• 311820-03-8 3-(3,5-dimethoxyphenyl)-N²,N²-bis(4-methoxybenzyl)-N⁷-trityl-1,6-naphthyridine-2,7-diamine 
• 13388-75-5 3,5-dimethoxyphenylacetonitrile 
• 179343-43-2 4,6-Diaminonicotinaldehyde 

Downstream Products

• 293301-35-6 3-(3,5-Dimethoxyphenyl)-7-{[3-(4-methylpiperazin-1-yl)propyl]amino}-1,6-naphthyridin-2-amine 
• 311820-03-8 3-(3,5-dimethoxyphenyl)-N²,N²-bis(4-methoxybenzyl)-N⁷-trityl-1,6-naphthyridine-2,7-diamine 
• 311820-04-9 3-(3,5-dimethoxyphenyl)-N²,N²-bis(4-methoxybenzyl)-1,6-naphthyridine-2,7-diamine 
• 311819-90-6 N-[2-[[(tert-butylamino)carbonyl]amino]-3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-7-yl]acetamide 
• 311819-88-2 1-[7-amino-3-(3,5-dimethoxy-phenyl)-[1,6]naphthyridin-2-yl]-3-tert-butyl-urea 
• 311819-96-2 3-(3,5-dimethoxyphenyl)-N²,N²,N⁷,N⁷-tetrakis(4-methoxybenzyl)-1,6-naphthyridine-2,7-diamine 
• 311820-00-5 3-(3,5-dimethoxyphenyl)-N⁷-trityl-1,6-naphthyridine-2,7-diamine 
• 311819-99-5 3-(3,5-dimethoxyphenyl)-7-(tritylamino)-1,6-naphthyridin-2-ylformamide 

Relevant articles and documents

3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase

A series of 3-aryl-1,6-naphthyridine-2,7-diamines and related 2-ureas were prepared and evaluated as inhibitors of the FGF receptor-1 tyrosine kinase. Condensation of 4,6-diaminonicotinaldehyde and substituted phenylacetonitriles gave intermediate naphthy